Back to Search Start Over

Assessment of patient and provider attitudes towards therapeutic drug monitoring to improve medication adherence in low-income patients with hypertension: a qualitative study

Authors :
Kevin B Schesing
Ricardo Chia
Bryan Elwood
Ethan A Halm
Simon J Craddock Lee
Hamza Lodhi
Bryan Wu
Shishir Sharma
Scott A Smith
Robin B Jarrett
Sandeep R Das
Wanpen Vongpatanasin
Source :
BMJ Open, Vol 10, Iss 11 (2020)
Publication Year :
2020
Publisher :
BMJ Publishing Group, 2020.

Abstract

Objectives Previous studies have implicated therapeutic drug monitoring (TDM), by measuring serum or urine drug levels, as a highly reliable technique for detecting medication non-adherence but the attitudes of patients and physicians toward TDM have not been evaluated previously. Accordingly, we solicited input from patients with uncontrolled hypertension and their physicians about their views on TDM.Design Prospective analysis of responses to a set of questions during semistructured interviews.Setting Outpatient clinics in an integrated health system which provides care for a low-income, uninsured population.Participants Patients with uncontrolled hypertension with either systolic blood pressure of at least 130 mm Hg or diastolic blood pressure of at least 80 mm Hg despite antihypertensive drugs and providers in the general cardiology and internal medicine clinics.Primary and secondary outcome measures Attitudes towards TDM and the potential impact on physician–patient relationship.Results We interviewed 11 patients and 10 providers and discussed the findings with 13 community advisory panel (CAP) members. Of the patients interviewed, 91% (10 of 11) and all 10 providers thought TDM was a good idea and should be used regularly to better understand the reasons for poorly controlled hypertension. However, 63% (7 of 11) of patients and 20% of providers expressed reservations that TDM could negatively impact the physician–patient relationship. Despite some concerns, the majority of patients, providers and CAP members believed that if test results are communicated without blaming patients, the potential benefits of TDM in identifying suboptimal adherence and eliciting barriers to adherence outweighed the risks.Conclusion The idea of TDM is well accepted by patients and their providers. TDM information if delivered in a non-judgmental manner, to encourage an honest conversation between patients and physicians, has the potential to reduce patient–physician communication obstacles and to identify barriers to adherence which, when overcome, can improve health outcomes.

Subjects

Subjects :
Medicine

Details

Language :
English
ISSN :
20446055
Volume :
10
Issue :
11
Database :
Directory of Open Access Journals
Journal :
BMJ Open
Publication Type :
Academic Journal
Accession number :
edsdoj.9bed4c3ddede45c69d6daceb651e877f
Document Type :
article
Full Text :
https://doi.org/10.1136/bmjopen-2020-039940